M. Kathleen Behrens - 27 Jan 2026 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
29 Jan 2026, 20:04:03 UTC
Prior SEC filing
14 Aug 2025
Next SEC filing
05 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Cristin L. Rothfuss, as Attorney-in-Fact for M. Kathleen Behrens

Key filing fact

M. Kathleen Behrens filed Form 4 for Sarepta Therapeutics, Inc. (SRPT) on 29 Jan 2026.

Key facts

  • This page summarizes M. Kathleen Behrens's Form 4 filing for Sarepta Therapeutics, Inc. (SRPT).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 29 Jan 2026, 20:04.

Change

  • Previous filing in this sequence was filed on 14 Aug 2025.
  • Current net transaction value: -$16.98.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001211701 Primary reporting owner

BEHRENS M KATHLEEN

Relationship
Director
Address
215 FIRST STREET, SUITE 415, CAMBRIDGE
Signature
/s/ Cristin L. Rothfuss, as Attorney-in-Fact for M. Kathleen Behrens
Signature date
29 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SRPT transaction

Common Stock

Options Exercise

Transaction value
$143,955
Shares
+10,500
Change %
+5.4%
Price
$13.71
Shares after
203,976
Date
27 Jan 2026
Ownership
Direct
SRPT transaction

Common Stock

Tax liability

Transaction value
$143,972
Shares
-6,494
Change %
-3.2%
Price
$22.17
Shares after
197,482
Date
27 Jan 2026
Ownership
Direct
Footnotes
F1
SRPT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
10,000
Date
27 Jan 2026
Ownership
By Trust

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SRPT transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
+10,500
Change %
Price
$0.000000
Shares after
0
Date
27 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
10,500
Exercise price
$13.71
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares withheld by the Issuer to satisfy payment by the Reporting Person of the option exercise price. The Reporting Person holds the exercised shares not withheld by the Issuer.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .